SMN1 and Pelizeaus-Merzbacher spectrum disorder: Notably, genetic evaluation excluded a differential diagnosis of alternate conditions, including spinal muscular atrophy (SMA), through negative SMN1/SMN2 deletion/duplication analysis, and Pelizaeus-Merzbacher disease, as PLP1 mutation analysis was negative.